Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Nat Prod
2022 May 27;855:1201-1210. doi: 10.1021/acs.jnatprod.1c00840.
Show Gene links
Show Anatomy links
Clerodane Diterpenes from Casearia corymbosa as Allosteric GABAA Receptor Modulators.
Syafni N
,
Faleschini MT
,
Garifulina A
,
Danton O
,
Gupta MP
,
Hering S
,
Hamburger M
.
???displayArticle.abstract???
An EtOAc extract of Casearia corymbosa leaves led to an allosteric potentiation of the GABA signal in a fluorometric imaging plate reader (FLIPR) assay on Chinese hamster ovary (CHO) cells stably expressing GABAA receptors with an α1β2γ2 subunit composition. The activity was tracked by HPLC-based activity profiling, and four known (2, 3, 4, and 8) and five new clerodane-type diterpenoids (1, 5-7, and 9) were isolated. Compounds 1-8 were obtained from the active time window. The absolute configuration of all compounds was established by ECD. Compounds 3, 7, and 8 exhibited EC50 values of 0.5, 4.6, and 1.4 μM, respectively. To explore possible binding sites at the receptor, the most abundant diterpenoid 8 was tested in combination with diazepam, etazolate, and allopregnanolone. An additive potentiation of the GABA signal was observed with these compounds, while the effect of 8 was not inhibited by flumazenil, a negative allosteric modulator at the benzodiazepine binding site. Finally, the activity was validated in voltage clamp studies on Xenopus laevis oocytes transiently expressing GABAA receptors of the α1β2γ2S and α1β2 subtypes. Compound 8 potentiated GABA-induced currents with both receptor subunit compositions [EC50 (α1β2γ2S) = 43.6 μM; Emax = 809% and EC50 (α1β2) = 57.6 μM; Emax = 534%]. The positive modulation of GABA-induced currents was not inhibited by flumazenil, thereby confirming an allosteric modulation independent of the benzodiazepine binding site.
Akk,
Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit.
2001, Pubmed
Akk,
Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit.
2001,
Pubmed
Alvarez,
In Search of GABAA Receptor's Neurosteroid Binding Sites.
2019,
Pubmed
Alvarez,
Structure and dynamics of neurosteroid binding to the α1β2γ2 GABAA receptor.
2018,
Pubmed
Baburin,
Automated fast perfusion of Xenopus oocytes for drug screening.
2006,
Pubmed
,
Xenbase
Baxter,
A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels.
2002,
Pubmed
Chen,
Multiple functional neurosteroid binding sites on GABAA receptors.
2019,
Pubmed
,
Xenbase
Joesch,
Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABA(A) receptor.
2008,
Pubmed
Khom,
Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity.
2007,
Pubmed
,
Xenbase
Khom,
Pharmacological properties of GABAA receptors containing gamma1 subunits.
2006,
Pubmed
,
Xenbase
Laverty,
Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites.
2017,
Pubmed
Laverty,
Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer.
2019,
Pubmed
Li,
Clerodane diterpenes: sources, structures, and biological activities.
2016,
Pubmed
Liu,
Clerodane Diterpenoids Isolated from the Leaves of Casearia graveolens.
2020,
Pubmed
Masiulis,
GABAA receptor signalling mechanisms revealed by structural pharmacology.
2019,
Pubmed
Mienville,
Pregnenolone sulfate antagonizes GABAA receptor-mediated currents via a reduction of channel opening frequency.
1989,
Pubmed
Möhler,
Agonist and antagonist benzodiazepine receptor interaction in vitro.
1981,
Pubmed
Moradi-Afrapoli,
HPLC-Based Activity Profiling for GABAA Receptor Modulators in Extracts: Validation of an Approach Utilizing a Larval Zebrafish Locomotor Assay.
2017,
Pubmed
,
Xenbase
Olsen,
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
2008,
Pubmed
Olsen,
GABAA receptor subtypes: the "one glass of wine" receptors.
2007,
Pubmed
Olsen,
GABAA receptor: Positive and negative allosteric modulators.
2018,
Pubmed
Potterat,
Combined use of extract libraries and HPLC-based activity profiling for lead discovery: potential, challenges, and practical considerations.
2014,
Pubmed
Potterat,
Concepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with bioassays.
2013,
Pubmed
Puthenkalam,
Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?
2016,
Pubmed
Sieghart,
Allosteric modulation of GABAA receptors via multiple drug-binding sites.
2015,
Pubmed
Sigel,
Structure, function, and modulation of GABA(A) receptors.
2012,
Pubmed
Smith,
Benzodiazepine modulation of recombinant alpha1beta3gamma2 GABA(A) receptor function efficacy determination using the Cytosensor microphysiometer.
1998,
Pubmed
Smith,
Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.
2001,
Pubmed
Smith,
Methodological approaches for the study of GABA(A) receptor pharmacology and functional responses.
2003,
Pubmed
Uusi-Oukari,
Regulation of GABA(A) receptor subunit expression by pharmacological agents.
2010,
Pubmed
Wallner,
Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans.
2003,
Pubmed
,
Xenbase
Zaugg,
HPLC-based activity profiling of Angelica pubescens roots for new positive GABAA receptor modulators in Xenopus oocytes.
2011,
Pubmed
,
Xenbase
Zaugg,
HPLC-based activity profiling: discovery of piperine as a positive GABA(A) receptor modulator targeting a benzodiazepine-independent binding site.
2010,
Pubmed
,
Xenbase
Zhu,
Structure of a human synaptic GABAA receptor.
2018,
Pubmed
